Medtronic PLC
NYSE:MDT

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
NYSE:MDT
Watchlist
Price: 81.54 USD 0.17% Market Closed
Market Cap: 104.6B USD
Have any thoughts about
Medtronic PLC?
Write Note

Operating Margin
Medtronic PLC

19.1%
Current
20%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
19.1%
=
Operating Profit
6.3B
/
Revenue
33B

Operating Margin Across Competitors

Country IE
Market Cap 104.6B USD
Operating Margin
19%
Country US
Market Cap 199B USD
Operating Margin
17%
Country US
Market Cap 191.3B USD
Operating Margin
26%
Country US
Market Cap 141.3B USD
Operating Margin
22%
Country US
Market Cap 134.2B USD
Operating Margin
18%
Country US
Market Cap 65.6B USD
Operating Margin
14%
Country DE
Market Cap 58.1B EUR
Operating Margin
12%
Country US
Market Cap 44.5B USD
Operating Margin
28%
Country CN
Market Cap 311.1B CNY
Operating Margin
36%
Country US
Market Cap 36.1B USD
Operating Margin
13%
Country US
Market Cap 34.1B USD
Operating Margin
30%
No Stocks Found

Medtronic PLC
Glance View

Market Cap
104.6B USD
Industry
Health Care
Economic Moat
Narrow

In the intricate world of medical technology, Medtronic PLC stands tall as one of the foremost innovators transforming the landscape of healthcare. Founded in 1949 as a humble medical supply repair shop in Minnesota, Medtronic has grown into a global titan, driven by the enduring mission to alleviate pain, restore health, and extend life. The company's breadth is vast, touching nearly every aspect of patient care, from advanced robotic-assisted surgery systems to sophisticated insulin pumps. At its core, Medtronic thrives on relentless research and development, continually bridging the gap between cutting-edge technology and practical medical solutions. By forging deep alliances with healthcare providers and systems around the globe, the company ensures its innovations are not only groundbreaking but also widely accessible. The company's financial engine purrs to life primarily through the development and sale of medical devices across four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies, Restorative Therapies Group, and Diabetes Group. Each unit meticulously focuses on innovating and providing solutions relevant to its field, ensuring a diversified portfolio with robust pipelines. For instance, within the Cardiac and Vascular Group, Medtronic supplies life-saving products like pacemakers and stents while also exploring breakthrough therapies such as transcatheter heart valves. By capitalizing on a global presence, the company strategically taps into both mature markets in North America and Europe and emerging markets across Asia and Latin America, thereby driving substantial revenue streams. Through this multifaceted operational framework, Medtronic not only sustains its market dominance but also reinvests in the future of medical technology, symbolizing a perpetual cycle of growth and innovation.

MDT Intrinsic Value
99.45 USD
Undervaluation 18%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
19.1%
=
Operating Profit
6.3B
/
Revenue
33B
What is the Operating Margin of Medtronic PLC?

Based on Medtronic PLC's most recent financial statements, the company has Operating Margin of 19.1%.